HSBC Holdings’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-24,665
Closed -$30.1K 2980
2025
Q2
$30.1K Buy
+24,665
New +$35.8K ﹤0.01% 2967
2024
Q3
Sell
-12,103
Closed -$50.3K 3087
2024
Q2
$50.3K Sell
12,103
-4,636
-28% -$45.1K ﹤0.01% 2817
2024
Q1
$246K Buy
+16,739
New +$253K ﹤0.01% 2564
2023
Q1
Sell
-15,655
Closed -$104K 2896
2022
Q4
$104K Sell
15,655
-2,264
-13% -$12.4K ﹤0.01% 2905
2022
Q3
$63K Buy
17,919
+1,934
+12% +$7.4K ﹤0.01% 2800
2022
Q2
$47K Buy
+15,985
New +$84K ﹤0.01% 3146

Other funds holding MGNX

HSBC Holdings's MGNX Position: Q3 2025 in Review

HSBC Holdings sold out of MacroGenics (MGNX) in Q3 2025, closing a stake of 24,665 shares — an estimated $30.1K sold.

HSBC Holdings first reported a position in MGNX in Q2 2022 and held it in 6 quarters. The position peaked at $246K in Q1 2024. 104 funds tracked by Wall St. Rank hold MGNX as of Q3 2025.

  • HSBC Holdings reported no remaining MacroGenics position as of Q3 2025 after selling out during the quarter.
  • HSBC Holdings sold 24,665 MacroGenics shares in Q3 2025, an estimated $30.1K.
  • HSBC Holdings first reported a position in MacroGenics in Q2 2022 and held it in 6 quarters.
  • HSBC Holdings's MacroGenics position peaked at $246K in Q1 2024.
  • 104 funds tracked by Wall St. Rank held MacroGenics as of Q3 2025.

Based on HSBC Holdings's 13F filing for Q3 2025, filed 13 Nov 2025.